Inozyme Pharma Ratios and Metrics

Market cap in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2010	FY 2009	FY 2008	FY 2007
Period Ending	Aug '25 Aug 7, 2025	Mar '10 Mar 31, 2010	Mar '09 Mar 31, 2009	Mar '08 Mar 31, 2008	Mar '07 Mar 31, 2007
Market Capitalization	15,275	1,878	1,361	2,206	3,158
Market Cap Growth	23.79%	37.96%	-38.29%	-30.14%	-
Enterprise Value	-	917	1,461	2,046	3,219
Last Close Price	2439.00	199.15	139.54	216.44	301.21
PE Ratio	38.46	4.61	14.45	22.68	-
PS Ratio	0.76	0.10	0.07	0.13	0.20
PB Ratio	2.15	0.27	0.21	0.33	0.48
P/TBV Ratio	2.16	0.27	0.21	0.34	0.48
P/FCF Ratio	19.82	0.75	-	-	-
P/OCF Ratio	18.83	0.74	-	-	-
EV/Sales Ratio	-	0.05	0.08	0.12	0.20
EV/EBITDA Ratio	-	1.13	3.11	7.62	-
EV/EBIT Ratio	-	1.27	3.80	11.34	-
EV/FCF Ratio	-	0.37	-	-	-
Debt / Equity Ratio	0.17	0.21	0.46	0.23	0.24
Debt / EBITDA Ratio	1.16	1.83	6.49	5.77	-
Debt / FCF Ratio	1.52	0.60	-	-	-
Asset Turnover	1.71	1.31	1.43	1.38	-
Inventory Turnover	8.77	8.35	10.05	8.49	-
Quick Ratio	1.77	1.69	1.56	1.69	1.80
Current Ratio	2.32	2.19	1.84	2.14	2.30
Return on Equity (ROE)	5.79%	5.98%	1.42%	1.47%	-
Return on Assets (ROA)	4.83%	3.20%	1.81%	0.94%	-
Return on Capital (ROIC)	6.95%	4.97%	2.69%	1.38%	-
Return on Capital Employed (ROCE)	10.80%	7.90%	4.30%	2.20%	-
Earnings Yield	2.62%	21.69%	6.92%	4.41%	-10.30%
FCF Yield	5.04%	132.55%	-43.34%	-8.29%	-14.98%
Dividend Yield	3.57%	5.02%	7.17%	4.62%	3.32%
Payout Ratio	15.65%	15.42%	66.43%	64.52%	-
Buyback Yield / Dilution	-	-	0.00%	0.00%	-
Total Shareholder Return	3.57%	5.02%	7.17%	4.62%	3.32%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.